Quantum Dot Probes for Single Exosome Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting tumor-derived exosomes in biofluids are limited by contamination from non-tumor exosomes, leading to reduced sensitivity and inability to quantify target-specific exosomes, due to the heterogeneity of tumors and the presence of cancer markers on normal cells, necessitating a more sensitive and quantitative approach at the single exosome level.
Innovation Solution
The use of fluorescence nanoparticles, such as quantum dots and dye-coated magnetic nanoparticles, for capturing and detecting extracellular vesicles at the single exosome level, employing a system with a planar support coated with capture molecules and a laser for excitation, allowing for precise labeling and characterization of exosomes through fluorescence imaging.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If bulk protein methods (western blotting, ELISA, mass spectrometry) are used to analyze exosomes, then the analysis can be performed on total exosome populations, but the detection sensitivity is reduced due to contamination from non-tumor exosomes and inability to quantify target-specific exosomes
Solution Approach 1:
The patent segments the bulk exosome population into individual single exosomes for analysis. By examining exosomes one at a time rather than in bulk, the system can identify and count only those exosomes that are positive for tumor markers, thereby achieving accurate quantification of target-specific exosomes despite the presence of contaminating non-tumor exosomes in the sample
Solution Approach 2:
The patent employs fluorescently labeled antibodies that emit detectable signals when bound to tumor markers on exosomes. This color/fluorescence change enables optical detection and discrimination of tumor-derived exosomes from non-tumor exosomes, significantly improving detection sensitivity and specificity
2Reliability
If conventional flow cytometry is used for exosome detection, then the method can analyze exosomes in suspension, but the accuracy is reduced due to high background, false positives, and size limitations (works well with size >300 nm)
Solution Approach 1:
The patent replaces the mechanical flow cytometry system with an optical microscopy-based system. This substitution eliminates the size limitations and background interference problems of flow cytometry, enabling accurate detection of small exosomes (30-150 nm) with high reliability through direct visual observation and fluorescent signal detection
3Measurement precision
If fluorescent imaging with dye molecules is used for single exosome detection, then the method can visualize individual exosomes, but the sensitivity is insufficient due to the low sensitivity of dye molecules at single-digit antigen levels
Solution Approach 1:
The patent uses composite fluorescent probes consisting of quantum dots (or other fluorescent nanoparticles) conjugated to antibodies. The quantum dots provide extremely bright and stable fluorescence signals that can be detected even when only a single tumor marker antigen is present on the exosome surface, thereby achieving the required detection sensitivity while maintaining methodological simplicity
4Quantity of substance
If tumor-derived exosomes are extracted from biofluids using bulk methods, then the total exosome population can be obtained, but the purity is reduced due to contamination with normal exosomes from various tissues and hematopoietic cells
Solution Approach 1:
The patent extracts the specific information needed (tumor marker presence) from each individual exosome rather than attempting to physically separate pure tumor exosomes from normal exosomes. By examining molecular markers on single exosomes, the method identifies and quantifies tumor-derived exosomes within the total population without requiring physical purification, thus maintaining both yield and effective purity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables sensitive and quantitative detection of tumor-derived exosomes, overcoming contamination issues and allowing for the analysis of small sample volumes, thereby improving early cancer detection and monitoring.
Implementation Method 1
an extracellular vesicle comprising a fluorescent probe, wherein the extracellular vesicle is bound to a capture molecule covalently bound to a film coating the planar support
Implementation Method 2
a laser tuned to emit a wavelength that can effectively excite the fluorescent probe
Data Source
AI summary
The present disclosure features compositions and methods related to the detection and molecular profiling of extracellular vesicles using fluorescent probes. These compositions and methods leverage the unique optoelectrical properties of quantum dots and fluorescently labeled nanoparticles, which allows reliable, real-time detection of extracellular vesicles and vesicle surface bound or lumenal molecules.